(Q33330243)

English

Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Philip E Knapp

1

0 references

object named as

Anqi Zhang

8

0 references

object named as

Karen L Herbst

3

0 references

Michael LaValley

object named as

Michael LaValley

7

0 references

Shalender Bhasin

10

object named as

Shalender Bhasin

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Thomas W Storer

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Atam B Singh

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Connie Dzekov

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Jeanne Dzekov

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Jagadish Ulloor

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

22 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

294

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

E1135-43

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Oxandrolone in AIDS-wasting myopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Testosterone dose-response relationships in healthy young men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

A trial of testosterone therapy for HIV-associated weight loss

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Oxandrolone in the Treatment of HIV-Associated Weight Loss in Men

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Predictors of mortality among HIV-infected women in Kigali, Rwanda

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Cross-sectional and longitudinal evaluation of body composition in men with HIV infection

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

DHEA in elderly women and DHEA or testosterone in elderly men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Androgen treatment of depressive symptoms in older men: a systematic review of feasibility and effectiveness

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90213.2008

21 January 2018

Identifiers

10.1152/AJPENDO.90213.2008

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33330243&oldid=1567462524"